Literature DB >> 25685641

Current Diagnostic and Therapeutic Strategies in Microvascular Angina.

Bryn Mumma1, Nathalie Flacke2.   

Abstract

Microvascular angina is common among patients with signs and symptoms of acute coronary syndrome and is associated with an increased risk of cardiovascular and cerebrovascular events. Unfortunately, microvascular is often under-recognized in clinical settings. The diagnosis of microvascular angina relies on assessment of the functional status of the coronary microvasculature. Invasive strategies include acetylcholine provocation, intracoronary Doppler ultrasound, and intracoronary thermodilution; noninvasive strategies include cardiac positron emission tomography (PET), cardiac magnetic resonance, and Doppler echocardiography. Once the diagnosis of microvascular angina is established, treatment is focused on improving symptoms and reducing future risk of cardiovascular and cerebrovascular events. Pharmacologic options and lifestyle modifications for patients with microvascular angina are similar to those for patients with coronary artery disease.

Entities:  

Keywords:  Cardiac syndrome X; Microvascular angina

Year:  2015        PMID: 25685641      PMCID: PMC4326009          DOI: 10.1007/s40138-014-0059-1

Source DB:  PubMed          Journal:  Curr Emerg Hosp Med Rep        ISSN: 2167-4884


  87 in total

1.  Coronary thermodilution to assess flow reserve: experimental validation.

Authors:  B De Bruyne; N H Pijls; L Smith; M Wievegg; G R Heyndrickx
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

2.  Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X.

Authors:  Xinling Zhang; Qiang Li; Jing Zhao; Xiangting Li; Xiaofei Sun; Hongyan Yang; Zongyin Wu; Jianmin Yang
Journal:  Coron Artery Dis       Date:  2014-01       Impact factor: 1.439

3.  2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

Review 4.  Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management.

Authors:  Kamlesh Kothawade; C Noel Bairey Merz
Journal:  Curr Probl Cardiol       Date:  2011-08       Impact factor: 5.200

5.  In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Daniel F Pauly; B Delia Johnson; R David Anderson; Eileen M Handberg; Karen M Smith; Rhonda M Cooper-DeHoff; George Sopko; Barry M Sharaf; Sheryl F Kelsey; C Noel Bairey Merz; Carl J Pepine
Journal:  Am Heart J       Date:  2011-09-06       Impact factor: 4.749

6.  Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X).

Authors:  Peter Ong; Ramyya Sivanathan; Gabor Borgulya; Mukhtar Bizrah; Yassir Iqbal; Joycelyn Andoh; David Gaze; Juan Carlos Kaski
Journal:  Cardiovasc Drugs Ther       Date:  2012-06       Impact factor: 3.727

7.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.

Authors:  Lasse Jespersen; Anders Hvelplund; Steen Z Abildstrøm; Frants Pedersen; Søren Galatius; Jan K Madsen; Erik Jørgensen; Henning Kelbæk; Eva Prescott
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

8.  Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction.

Authors:  Megha Agarwal; Chrisandra Shufelt; Puja K Mehta; Edward Gill; Daniel S Berman; Debiao Li; Behzad Sharif; Ning Li; C Noel Bairey Merz; Louise E J Thomson
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

9.  Pilot study testing the effect of physical training over the myocardial perfusion and quality of life in patients with primary microvascular angina.

Authors:  Eduardo Elias Vieira de Carvalho; Giovani Luiz Santi; Júlio César Crescêncio; Luciano Fonseca Lemos de Oliveira; Daniela Caetano Costa dos Reis; Alexandre Baldini Figueiredo; Antonio Osvaldo Pintya; Moyses Oliveira Lima-Filho; Lourenço Gallo-Júnior; José Antonio Marin-Neto; Marcus Vinícius Simões
Journal:  J Nucl Cardiol       Date:  2014-08-01       Impact factor: 5.952

10.  Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance.

Authors:  Sujethra Vasu; W Patricia Bandettini; Li-Yueh Hsu; Peter Kellman; Steve Leung; Christine Mancini; Sujata M Shanbhag; Joel Wilson; Oscar Julian Booker; Andrew E Arai
Journal:  J Cardiovasc Magn Reson       Date:  2013-09-24       Impact factor: 5.364

View more
  1 in total

Review 1.  Traditional chinese medicine in coronary microvascular disease.

Authors:  Zhihua Yang; Shanshan Lin; Yangxi Liu; Qiuan Ren; Zhao Ge; Ci Wang; Yingfei Bi; Xianliang Wang; Jingyuan Mao
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.